Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
A receptor antagonist is a substance that binds to a receptor and reduces or prevents activation by an agonist. A neutral antagonist has affinity for the receptor but little or no intrinsic activating effect. It can block an endogenous messenger, medicine, toxin, or another ligand from producing its usual response. The effect depends on the receptor, binding site, affinity, concentration, and duration of binding.
read more about receptor antagonist ...A competitive antagonist commonly binds reversibly to the same receptor site used by an agonist. Increasing the agonist concentration can overcome this blockade under suitable conditions. A noncompetitive antagonist can bind irreversibly or act at another site so that raising agonist concentration does not fully restore the maximum response. Some antagonists reduce signaling indirectly by preventing receptor coupling or access.
Competitive, noncompetitive, irreversible, and allosteric antagonists are classified according to how they block receptor signaling. Neutral antagonists block agonist effects without reducing the receptor's baseline activity. Inverse agonists reduce constitutive receptor activity and are pharmacologically distinct from neutral antagonists. Functional antagonism occurs when two drugs act at different receptors but produce opposing physiological effects.
Naloxone blocks opioid receptors and can reverse opioid-induced respiratory depression. Beta blockers antagonize beta adrenergic receptors, while antihistamines commonly block or inversely activate signaling at histamine receptors. Angiotensin receptor blockers reduce angiotensin II signaling at AT1 receptors. Receptor selectivity determines the intended action and many of the adverse effects.
Blocking normal receptor signaling can cause adverse effects as well as therapeutic benefits. A high-affinity antagonist can abruptly reverse an agonist effect or trigger withdrawal in a physically dependent patient. Duration can outlast or be shorter than the agonist being blocked, which can require repeat dosing or continued monitoring. Other medicines, receptor adaptations, organ function, and disease state can change the response.
A neutral antagonist binds without activating the receptor and blocks agonist signaling. An inverse agonist goes further by reducing constitutive receptor activity.
Yes. Naloxone is an opioid receptor antagonist that can rapidly reverse opioid-induced respiratory depression. Its effect can wear off before that of a long-acting opioid.
A reversible competitive antagonist can sometimes be overcome by increasing agonist concentration. Irreversible or noncompetitive antagonism cannot usually be overcome fully in that way.
Broadly, an agonist activates a receptor and an antagonist blocks agonist-mediated activation. Inverse agonists and functional antagonists add more complexity to that comparison.
Definition of Antagonist. National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antagonist. Date Accessed August 6, 2026.
Pharmacodynamics. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK507791/. Date Accessed August 6, 2026.
Drug-Receptor Interactions in Anaesthesia. BJA Education (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC8703152/. Date Accessed August 6, 2026.
Analytical Pharmacology: How Numbers Can Guide Drug Discovery. British Journal of Pharmacology (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC7088946/. Date Accessed August 6, 2026.
Opioid Antagonists. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK537079/. Date Accessed August 6, 2026.